Current Signal Transduction Therapy

Scopus Cite Score: 1.9

Aims and Scope: In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders. The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.

Read more...

Editor-in-Chiefcasc:

  • Jingxuan Yang Department of Medicine
    The University of Oklahoma Health Science Center
    Oklahoma City, OK
    USA

ISSN: 1574-3624 (Print)

eISSN: 2212-389X (Online)

Special Issues With Active Call for Papers

Submission closes on: Jan 02, 2026
Metabolism in Inflammation-Induced Cancer

We will talk about the primary mechanisms and principles of inflammation-induced cancer based on the most recent research findings and our understanding of the tumor development process, with an emphasis on the crosstalk between metabolism and inflammation-induced cancer. The regulatory mechanisms of T cell subpopulation differentiation, the regulatory function of metabolites in inflammation-induced cancer, the regulatory role of metabolism in tumor immunity, and the role of metabolites in autoimmune illnesses are just a few of... see more